par Vermorken, Jan Baptist;ten Bokkel Huinink, Wim;Kobierska, A;van der Burg, Maria;Forni, Mario;Piccart-Gebhart, Martine ;van der Putten, E
Référence Oncology, 57, 1, page (10-16)
Publication Publié, 1999-07
Référence Oncology, 57, 1, page (10-16)
Publication Publié, 1999-07
Article révisé par les pairs
Titre: |
|
Auteur: | Vermorken, Jan Baptist; ten Bokkel Huinink, Wim; Kobierska, A; van der Burg, Maria; Forni, Mario; Piccart-Gebhart, Martine; van der Putten, E |
Informations sur la publication: | Oncology, 57, 1, page (10-16) |
Statut de publication: | Publié, 1999-07 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Adult |
Antibiotics, Antineoplastic -- administration & dosage | |
Antibiotics, Antineoplastic -- adverse effects | |
Antibiotics, Antineoplastic -- therapeutic use | |
Antineoplastic Agents -- therapeutic use | |
Cisplatin -- therapeutic use | |
Drug Administration Schedule | |
Epirubicin -- administration & dosage | |
Epirubicin -- adverse effects | |
Epirubicin -- therapeutic use | |
Female | |
Humans | |
Leukopenia -- chemically induced | |
Middle Aged | |
Ovarian Neoplasms -- drug therapy | |
Thrombocytopenia -- chemically induced | |
Treatment Outcome | |
Note générale: | Clinical Trial |
Clinical Trial, Phase I | |
Journal Article | |
Langue: | Anglais |
Identificateurs: | urn:issn:0030-2414 |
info:pii/ocl57010 | |
info:pmid/10394119 |